Tuesday, 17 November 2026European Markets

ULTIMOVACS Stock Bearish By 34% In The Last 21 Sessions

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of ULTIMOVACS (Oslo Børs Benchmark Index_GI: ULTI.OL) fell by a staggering 34.14% in 21 sessions from kr123.6 to kr81.40 at 05:39 EST on Tuesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI is sliding 1.13% to kr1,231.97, following the last session's downward trend.

ULTIMOVACS's last close was kr81.40, 42.92% below its 52-week high of kr142.60.

About ULTIMOVACS

Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a peptide-based cancer vaccine that induces a specific T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-4.72.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -33.74%.

Moving Average

ULTIMOVACS's worth is way below its 50-day moving average of kr121.07 and way below its 200-day moving average of kr102.27.

Volatility

ULTIMOVACS's last week, last month's, and last quarter's current intraday variation average was a negative 0.09%, a negative 2.68%, and a positive 2.47%.

ULTIMOVACS's highest amplitude of average volatility was 0.95% (last week), 3.63% (last month), and 2.47% (last quarter).

Volume

Today's last reported volume for ULTIMOVACS is 170498 which is 161.47% above its average volume of 58081.

More news about ULTIMOVACS (ULTI.OL).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

  1. Published before we listed source documents with each article.
  2. Published 20 Jun 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›